Daniela Sylvia Beate Roxin
Profile
Daniela Sylvia Beate Roxin worked as the Chief Financial Officer at Consort Medical Ltd.
from 2021 to 2022 and also held the same position at Recipharm AB.
Former positions of Daniela Sylvia Beate Roxin
| Companies | Position | End |
|---|---|---|
| CONSORT MEDICAL PLC | Director/Board Member | 2022-10-31 |
| RECIPHARM AB (PUBL) | Director of Finance/CFO | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Consort Medical Ltd.
 Consort Medical Ltd. Pharmaceuticals: MajorHealth Technology Consort Medical Ltd. is a holding company, which engages in pharmaceutical industry related activities. It focuses on the design, development, manufacture, and sale of medical drug and delivery devices. The company was founded on March 22, 1946 and is headquartered in Kings Lynn, the United Kingdom. | Health Technology |
Recipharm AB
 Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Daniela Sylvia Beate Roxin